Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Occupational prestige, social mobility and the association with lung cancer in men

T. Behrens, I. Groß, J. Siemiatycki, DI. Conway, A. Olsson, I. Stücker, F. Guida, KH. Jöckel, H. Pohlabeln, W. Ahrens, I. Brüske, HE. Wichmann, P. Gustavsson, D. Consonni, F. Merletti, L. Richiardi, L. Simonato, C. Fortes, ME. Parent, J....

. 2016 ; 16 (-) : 395. [pub] 20160707

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18017172

BACKGROUND: The nature of the association between occupational social prestige, social mobility, and risk of lung cancer remains uncertain. Using data from the international pooled SYNERGY case-control study, we studied the association between lung cancer and the level of time-weighted average occupational social prestige as well as its lifetime trajectory. METHODS: We included 11,433 male cases and 14,147 male control subjects. Each job was translated into an occupational social prestige score by applying Treiman's Standard International Occupational Prestige Scale (SIOPS). SIOPS scores were categorized as low, medium, and high prestige (reference). We calculated odds ratios (OR) with 95 % confidence intervals (CI), adjusting for study center, age, smoking, ever employment in a job with known lung carcinogen exposure, and education. Trajectories in SIOPS categories from first to last and first to longest job were defined as consistent, downward, or upward. We conducted several subgroup and sensitivity analyses to assess the robustness of our results. RESULTS: We observed increased lung cancer risk estimates for men with medium (OR = 1.23; 95 % CI 1.13-1.33) and low occupational prestige (OR = 1.44; 95 % CI 1.32-1.57). Although adjustment for smoking and education reduced the associations between occupational prestige and lung cancer, they did not explain the association entirely. Traditional occupational exposures reduced the associations only slightly. We observed small associations with downward prestige trajectories, with ORs of 1.13, 95 % CI 0.88-1.46 for high to low, and 1.24; 95 % CI 1.08-1.41 for medium to low trajectories. CONCLUSIONS: Our results indicate that occupational prestige is independently associated with lung cancer among men.

Cancer Care Ontario Occupational Cancer Research Centre Toronto Canada

Dental School College of Medicine Veterinary and Life Sciences University of Glasgow Glasgow G2 3JZ UK

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University Brno Czech Republic

Department of Medical Sciences Unit of Cancer Epidemiology University of Turin Turin Italy

Department of Molecular Medicine Laboratory of Public Health and Population Studies University of Padova Padova Italy

Environmental Epidemiology Division Institute for Risk Assessment Sciences Utrecht University Utrecht The Netherlands

Epidemiology Unit Istituto Dermopatico dell'Immacolata Rome Italy

Faculty of Medicine Palacky University Olomouc Czech Republic Faculty of Medicine University of Ostrava Ostrava Czech Republic

Hospital Research Center and School of Public Health University of Montreal Montreal Canada

INRS Institut Armand Frappier Université du Québec Laval Québec Canada

Inserm Centre for Research in Epidemiology and Population Health U1018 Environmental Epidemiology of Cancer Team F 94807 Villejuif France University Paris Sud UMRS 1018 F 94807 Villejuif France

Institute for Medical Informatics Biometry and Epidemiology University Hospital Essen Essen Germany

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance Institute of the Ruhr Universität Bochum Bürkle de la Camp Platz 1 44789 Bochum Germany

Institute of Carcinogenesis Russian Cancer Research Centre Moscow Russia

Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Institute of Epidemiology 1 Helmholtz Zentrum München Neuherberg Germany

Institute of Epidemiology 1 Helmholtz Zentrum München Neuherberg Germany Institute of Medical Statistics and Epidemiology Technical University Munich Munich Germany

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

International Agency for Research on Cancer Lyon France

International Agency for Research on Cancer Lyon France Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Leibniz Institute for Prevention Research and Epidemiology BIPS GmbH Bremen Germany

Leibniz Institute for Prevention Research and Epidemiology BIPS GmbH Bremen Germany Institute for Statistics University Bremen Bremen Germany

Molecular Epidemiology of Cancer Unit University of Oviedo Ciber de Epidemiologia CIBERESP Oviedo Spain

National Cancer Institute Division of Cancer Epidemiology and Genetics Bethesda USA

National Centre for Public Health Budapest Hungary

National Institute of Public Health Bucharest Romania

Regional Authority of Public Health Preventive Occupational Medicine Banska Bystrica Slovakia

Roy Castle Lung Cancer Research Programme The University of Liverpool Cancer Research Centre Liverpool UK Department of Molecular and Clinical Cancer Medicine Institute of Translational Medicine University of Liverpool Liverpool UK

The M Sklodowska Curie Cancer Center and Institute of Oncology Warsaw Poland

The Nofer Institute of Occupational Medicine Lodz Poland

The Tisch Cancer Institute and Institute for Translational Epidemiology Icahn School of Medicine at Mount Sinai New York USA

Unit of Epidemiology Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017172
003      
CZ-PrNML
005      
20180517093717.0
007      
ta
008      
180515s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12885-016-2432-9 $2 doi
035    __
$a (PubMed)27388894
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Behrens, Thomas $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany. behrens@ipa-dguv.de.
245    10
$a Occupational prestige, social mobility and the association with lung cancer in men / $c T. Behrens, I. Groß, J. Siemiatycki, DI. Conway, A. Olsson, I. Stücker, F. Guida, KH. Jöckel, H. Pohlabeln, W. Ahrens, I. Brüske, HE. Wichmann, P. Gustavsson, D. Consonni, F. Merletti, L. Richiardi, L. Simonato, C. Fortes, ME. Parent, J. McLaughlin, P. Demers, MT. Landi, N. Caporaso, D. Zaridze, N. Szeszenia-Dabrowska, P. Rudnai, J. Lissowska, E. Fabianova, A. Tardón, JK. Field, RS. Dumitru, V. Bencko, L. Foretova, V. Janout, H. Kromhout, R. Vermeulen, P. Boffetta, K. Straif, J. Schüz, J. Hovanec, B. Kendzia, B. Pesch, T. Brüning,
520    9_
$a BACKGROUND: The nature of the association between occupational social prestige, social mobility, and risk of lung cancer remains uncertain. Using data from the international pooled SYNERGY case-control study, we studied the association between lung cancer and the level of time-weighted average occupational social prestige as well as its lifetime trajectory. METHODS: We included 11,433 male cases and 14,147 male control subjects. Each job was translated into an occupational social prestige score by applying Treiman's Standard International Occupational Prestige Scale (SIOPS). SIOPS scores were categorized as low, medium, and high prestige (reference). We calculated odds ratios (OR) with 95 % confidence intervals (CI), adjusting for study center, age, smoking, ever employment in a job with known lung carcinogen exposure, and education. Trajectories in SIOPS categories from first to last and first to longest job were defined as consistent, downward, or upward. We conducted several subgroup and sensitivity analyses to assess the robustness of our results. RESULTS: We observed increased lung cancer risk estimates for men with medium (OR = 1.23; 95 % CI 1.13-1.33) and low occupational prestige (OR = 1.44; 95 % CI 1.32-1.57). Although adjustment for smoking and education reduced the associations between occupational prestige and lung cancer, they did not explain the association entirely. Traditional occupational exposures reduced the associations only slightly. We observed small associations with downward prestige trajectories, with ORs of 1.13, 95 % CI 0.88-1.46 for high to low, and 1.24; 95 % CI 1.08-1.41 for medium to low trajectories. CONCLUSIONS: Our results indicate that occupational prestige is independently associated with lung cancer among men.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x epidemiologie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pracovní expozice $x škodlivé účinky $7 D016273
650    _2
$a odds ratio $7 D016017
650    _2
$a rizikové faktory $7 D012307
650    _2
$a kouření $x škodlivé účinky $x epidemiologie $7 D012907
650    _2
$a sociální mobilita $x statistika a číselné údaje $7 D012937
650    _2
$a socioekonomické faktory $7 D012959
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Groß, Isabelle $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany.
700    1_
$a Siemiatycki, Jack $u Hospital Research Center (CRCHUM) and School of Public Health, University of Montreal, Montreal, Canada.
700    1_
$a Conway, David I $u Dental School, College of Medicine Veterinary and Life Sciences, University of Glasgow, Glasgow, G2 3JZ, UK.
700    1_
$a Olsson, Ann $u International Agency for Research on Cancer (IARC), Lyon, France. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Stücker, Isabelle $u Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France. University Paris-Sud, UMRS 1018, F-94807, Villejuif, France.
700    1_
$a Guida, Florence $u Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Team, F-94807, Villejuif, France. University Paris-Sud, UMRS 1018, F-94807, Villejuif, France.
700    1_
$a Jöckel, Karl-Heinz $u Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.
700    1_
$a Pohlabeln, Hermann $u Leibniz-Institute for Prevention Research and Epidemiology -BIPS GmbH, Bremen, Germany.
700    1_
$a Ahrens, Wolfgang $u Leibniz-Institute for Prevention Research and Epidemiology -BIPS GmbH, Bremen, Germany. Institute for Statistics, University Bremen, Bremen, Germany.
700    1_
$a Brüske, Irene $u Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, Germany.
700    1_
$a Wichmann, Heinz-Erich $u Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, Germany. Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany.
700    1_
$a Gustavsson, Per $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Consonni, Dario $u Unit of Epidemiology, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
700    1_
$a Merletti, Franco $u Department of Medical Sciences, Unit of Cancer Epidemiology, University of Turin, Turin, Italy.
700    1_
$a Richiardi, Lorenzo $u Department of Medical Sciences, Unit of Cancer Epidemiology, University of Turin, Turin, Italy.
700    1_
$a Simonato, Lorenzo $u Department of Molecular Medicine, Laboratory of Public Health and Population Studies, University of Padova, Padova, Italy.
700    1_
$a Fortes, Cristina $u Epidemiology Unit, Istituto Dermopatico dell'Immacolata, Rome, Italy.
700    1_
$a Parent, Marie-Elise $u INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada.
700    1_
$a McLaughlin, John $u Cancer Care Ontario, Occupational Cancer Research Centre, Toronto, Canada.
700    1_
$a Demers, Paul $u Cancer Care Ontario, Occupational Cancer Research Centre, Toronto, Canada.
700    1_
$a Landi, Maria Teresa $u National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, USA.
700    1_
$a Caporaso, Neil $u National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, USA.
700    1_
$a Zaridze, David $u Institute of Carcinogenesis, Russian Cancer Research Centre, Moscow, Russia.
700    1_
$a Szeszenia-Dabrowska, Neonila $u The Nofer Institute of Occupational Medicine, Lodz, Poland.
700    1_
$a Rudnai, Peter $u National Centre for Public Health, Budapest, Hungary.
700    1_
$a Lissowska, Jolanta $u The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
700    1_
$a Fabianova, Eleonora $u Regional Authority of Public Health, Preventive Occupational Medicine, Banska Bystrica, Slovakia.
700    1_
$a Tardón, Adonina $u Molecular Epidemiology of Cancer Unit, University of Oviedo-Ciber de Epidemiologia, CIBERESP, Oviedo, Spain.
700    1_
$a Field, John K $u Roy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Liverpool, UK. Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
700    1_
$a Dumitru, Rodica Stanescu $u National Institute of Public Health, Bucharest, Romania.
700    1_
$a Bencko, Vladimir $u Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Foretova, Lenka $u Department of Cancer Epidemiology & Genetics, Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Brno, Czech Republic.
700    1_
$a Janout, Vladimir $u Faculty of Medicine, Palacky University, Olomouc, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Kromhout, Hans $u Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
700    1_
$a Vermeulen, Roel $u Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
700    1_
$a Boffetta, Paolo $u The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, USA.
700    1_
$a Straif, Kurt $u International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a Schüz, Joachim $u International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a Hovanec, Jan $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany.
700    1_
$a Kendzia, Benjamin $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany.
700    1_
$a Pesch, Beate $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany.
700    1_
$a Brüning, Thomas $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany.
773    0_
$w MED00008171 $t BMC cancer $x 1471-2407 $g Roč. 16, č. - (2016), s. 395
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27388894 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180517093854 $b ABA008
999    __
$a ok $b bmc $g 1300796 $s 1014012
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 16 $c - $d 395 $e 20160707 $i 1471-2407 $m BMC cancer $n BMC Cancer $x MED00008171
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace